Endocrinology, Vol 127, 2795-2803, Copyright © 1990 by Endocrine Society

ARTICLES

Structural and biological characterization of bovine insulin-like growth factor binding protein-3

CA Conover, M Ronk, F Lombana and DR Powell
Endocrine Research Unit, Mayo Clinic, Rochester, Minnesota 55905.

Insulin-like growth factor binding protein-3 (IGFBP-3) purified from bovine serum shares 19 of 25 amino-terminal amino acid residues with IGFBP-3 purified from human, rat, and porcine sources. A newly characterized bovine fibroblast model was used to investigate the biological effects of purified bovine IGFBP-3 (bIGFBP-3). Coincubation of insulin-like growth factor I (IGF-I) with increasing concentrations of bIGFBP-3 produced a dose-dependent inhibition of IGF-I-stimulated [3H]aminoisobutyric acid (AIB) uptake in cultured bovine fibroblasts. Inhibition was complete at equimolar concentrations of IGF-I and bIGFBP- 3. Inhibition of IGF-I-stimulated [3H]AIB uptake paralleled the ability of bIGFBP-3 to prevent [125I]IGF-I cell surface binding. In contrast, preincubation with bIGFBP-3 resulted in a dose-dependent enhancement of IGF-I-stimulated [3H]AIB uptake; a 32-86% increase in IGF-I bioactivity was seen after a 24 h preexposure to 10 nM bIGFBP-3, and a 2- to 6-fold potentiation was seen after a 72 h preincubation. Preincubation with bIGFBP-3 increased both the sensitivity and maximal responsiveness of the cells to IGF-I. The potentiating effects of bIGFBP-3 were associated with increased [125I]IGF-I binding to cultured bovine fibroblasts. Affinity cross-linking experiments indicated that the increase in IGF-I binding was due to increased membrane-associated bIGFBP-3 rather than to a bIGFBP-3-induced increase in type I IGF receptors. bIGFBP-3 had no effect on insulin stimulation of [3H]AIB uptake under either experimental condition. These data suggest that soluble bIGFBP-3 inhibits IGF-I action by sequestering and preventing IGF-I receptor binding, whereas surface-associated bIGFBP-3 enhances the growth-promoting effects of IGF-I in bovine fibroblasts. We propose that IGFBP-3 serves a dual function in modulating IGF action in vivo.

This article has been cited by other articles:

				M D Ashworth, J W Ross, D R Stein, D T Allen, L J Spicer, and R D Geisert Endocrine disruption of uterine insulin-like growth factor expression in the pregnant gilt Reproduction, October 1, 2005; 130(4): 545 - 551. [Abstract] [Full Text] [PDF]

				Y. Li, J. Xiang, and C. Duan Insulin-like Growth Factor-binding Protein-3 Plays an Important Role in Regulating Pharyngeal Skeleton and Inner Ear Formation and Differentiation J. Biol. Chem., February 4, 2005; 280(5): 3613 - 3620. [Abstract] [Full Text] [PDF]

				A. C. Baege, G. L. Disbrow, and R. Schlegel IGFBP-3, a Marker of Cellular Senescence, Is Overexpressed in Human Papillomavirus-Immortalized Cervical Cells and Enhances IGF-1-Induced Mitogenesis J. Virol., June 1, 2004; 78(11): 5720 - 5727. [Abstract] [Full Text] [PDF]

				E. M. Ongeri, Q. Zhu, M. F. Verderame, and J. M. Hammond Insulin-Like Growth Factor-Binding Protein-3 in Porcine Ovarian Granulosa Cells: Gene Cloning, Promoter Mapping, and Follicle-Stimulating Hormone Regulation Endocrinology, April 1, 2004; 145(4): 1776 - 1785. [Abstract] [Full Text] [PDF]

				K. L. Williams, C. R. Fuller, J. Fagin, and P. K. Lund Mesenchymal IGF-I overexpression: paracrine effects in the intestine, distinct from endocrine actions Am J Physiol Gastrointest Liver Physiol, October 1, 2002; 283(4): G875 - G885. [Abstract] [Full Text] [PDF]

				T. Modric, J. V. Silha, Z. Shi, Y. Gui, A. Suwanichkul, S. K. Durham, D. R. Powell, and L. J. Murphy Phenotypic Manifestations of Insulin-Like Growth Factor-Binding Protein-3 Overexpression in Transgenic Mice Endocrinology, May 1, 2001; 142(5): 1958 - 1967. [Abstract] [Full Text]

				C. A. Conover, L. K. Bale, S. K. Durham, and D. R. Powell Insulin-Like Growth Factor (IGF) Binding Protein-3 Potentiation of IGF Action Is Mediated through the Phosphatidylinositol-3-Kinase Pathway and Is Associated with Alteration in Protein Kinase B/AKT Sensitivity Endocrinology, September 1, 2000; 141(9): 3098 - 3103. [Abstract] [Full Text] [PDF]

				J. M. Pell, R. A. Hill, C. E. H. Stewart, C. R. Weston, and H. C. Flick-Smith Enhancement of Insulin-Like Growth Factor I Activity by Novel Antisera: Potential Structure/Function Interactions Endocrinology, February 1, 2000; 141(2): 741 - 751. [Abstract] [Full Text] [PDF]

				P. G. Campbell, S. K. Durham, J. D. Hayes, A. Suwanichkul, and D. R. Powell Insulin-like Growth Factor-binding Protein-3 Binds Fibrinogen and Fibrin J. Biol. Chem., October 15, 1999; 274(42): 30215 - 30221. [Abstract] [Full Text] [PDF]

				C. Agarwal, A. Lambert, R. A.S. Chandraratna, E. A. Rorke, and R. L. Eckert Vitamin D Regulates Human Ectocervical Epithelial Cell Proliferation and Insulin-Like Growth Factor-Binding Protein-3 Level Biol Reprod, March 1, 1999; 60(3): 567 - 572. [Abstract] [Full Text]

				S. L. Bradshaw, A. J. D’Ercole, and V. K. M. Han Overexpression of Insulin-Like Growth Factor-Binding Protein-2 in C6 Glioma Cells Results in Conditional Alteration of Cellular Growth Endocrinology, February 1, 1999; 140(2): 575 - 584. [Abstract] [Full Text]

				P. G. Campbell, S. K. Durham, A. Suwanichkul, J. D. Hayes, and D. R. Powell Plasminogen binds the heparin-binding domain of insulin-like growth factor-binding protein-3 Am J Physiol Endocrinol Metab, August 1, 1998; 275(2): E321 - E331. [Abstract] [Full Text] [PDF]

				L. J. Schedlich, T. F. Young, S. M. Firth, and R. C. Baxter Insulin-like Growth Factor-binding Protein (IGFBP)-3 and IGFBP-5 Share a Common Nuclear Transport Pathway in T47D Human Breast Carcinoma Cells J. Biol. Chem., July 17, 1998; 273(29): 18347 - 18352. [Abstract] [Full Text] [PDF]

				D. R. Powell, S. K. Durham, F. Liu, B. K. Baker, P. D. K. Lee, S. L. Watkins, P. G. Campbell, E. D. Brewer, R. L. Hintz, and R. J. Hogg The Insulin-Like Growth Factor Axis and Growth in Children with Chronic Renal Failure: A Report of the Southwest Pediatric Nephrology Study Group J. Clin. Endocrinol. Metab., May 1, 1998; 83(5): 1654 - 1661. [Abstract] [Full Text]

				Z. P. Gill, C. M. Perks, P. V. Newcomb, and J. M. P. Holly Insulin-like Growth Factor-binding Protein (IGFBP-3) Predisposes Breast Cancer Cells to Programmed Cell Death in a Non-IGF-dependent Manner J. Biol. Chem., October 10, 1997; 272(41): 25602 - 25607. [Abstract] [Full Text] [PDF]

				T. C. Haddad and C. A. Conover Insulin and Interleukin-4 Induce Desensitization to the Mitogenic Effects of Insulin-like Growth Factor-I. PIVOTAL ROLE FOR INSULIN RECEPTOR SUBSTRATE-2 J. Biol. Chem., August 1, 1997; 272(31): 19525 - 19531. [Abstract] [Full Text] [PDF]

				S. Xu, P. Savage, J. L. Burton, J. Sansom, and J. M. P. Holly Proteolysis of Insulin-Like Growth Factor-Binding Protein-3 by Human Skin Keratinocytes in Culture in Comparison to that in Skin Interstitial Fluid: The Role and Regulation of Components of the Plasmin System J. Clin. Endocrinol. Metab., June 1, 1997; 82(6): 1863 - 1868. [Abstract] [Full Text] [PDF]

				Z. S. Gucev, Y. Oh, K. M. Kelley, J. I. Labarta, P. Vorwerk, and R. G. Rosenfeld Evidence for Insulin-Like Growth Factor (IGF)-Independent Transcriptional Regulation of IGF Binding Protein-3 by Growth Hormone in SKHEP-1 Human Hepatocarcinoma Cells Endocrinology, April 1, 1997; 138(4): 1464 - 1470. [Abstract] [Full Text] [PDF]

				J. L. Fowlkes and D. M. Serra Characterization of Glycosaminoglycan-binding Domains Present in Insulin-like Growth Factor-binding Protein-3 J. Biol. Chem., June 21, 1996; 271(25): 14676 - 14679. [Abstract] [Full Text] [PDF]

				T. Arai, J. Clarke, A. Parker, W. Busby Jr., T. Nam, and D. R. Clemmons Substitution of Specific Amino Acids in Insulin-like Growth Factor (IGF) Binding Protein 5 Alters Heparin Binding and Its Change in Affinity for IGF-I in Response to Heparin J. Biol. Chem., March 15, 1996; 271(11): 6099 - 6106. [Abstract] [Full Text] [PDF]

				D. L. Andress and D. L. Andress Heparin Modulates the Binding of Insulin-like Growth Factor (IGF) Binding Protein-5 to a Membrane Protein in Osteoblastic Cells J. Biol. Chem., November 24, 1995; 270(47): 28289 - 28296. [Abstract] [Full Text] [PDF]

				Y. Oh, H. L. Müller, L. Ng, and R. G. Rosenfeld Transforming Growth Factor- [IMAGE]-induced Cell Growth Inhibition in Human Breast Cancer Cells Is Mediated through Insulin-like Growth Factor-binding Protein-3 Action J. Biol. Chem., June 9, 1995; 270(23): 13589 - 13592. [Abstract] [Full Text] [PDF]